M. Alexander Otto began his reporting career early in 1999 covering the pharmaceutical industry for a national pharmacists' magazine and freelancing for the Washington Post and other newspapers. He then joined BNA, now part of Bloomberg News, covering health law and the protection of people and animals in medical research. Alex next worked for the McClatchy Company. Based on his work, Alex won a year-long Knight Science Journalism Fellowship to MIT in 2008-2009. He joined the company shortly thereafter. Alex has a newspaper journalism degree from Syracuse (N.Y.) University and a master's degree in medical science -- a physician assistant degree -- from George Washington University. Alex is based in Seattle.
News
IV fluid weaning unnecessary after gastroenteritis rehydration
- Author:
- M. Alexander Otto
SEATTLE – Saving “even a couple hours” to get kids out of the hospital quicker matters.
News
Too many blood cultures ordered for pediatric SSTIs
- Author:
- M. Alexander Otto
SEATTLE – Culture draws were associated with a 20% increase in hospital length of stay.
News
Enteral feeding is safe during bronchiolitis HFNC
- Author:
- M. Alexander Otto
SEATTLE – Parents feel better when they know their children are “getting food in their belly.”
News
Short-course azithromycin no benefit in pediatric asthma admissions
- Author:
- M. Alexander Otto
SEATTLE – Clinicians should consider these data before prescribing azithromycin to children hospitalized with asthma.
News
DECLARE-TIMI58 shows improved kidney function with dapagliflozin
- Author:
- M. Alexander Otto
SAN FRANCISCO – The SGLT2 dapagliflozin was better than placebo at slowing down kidney disease in patients with type 2 diabetes
News
CARMELINA confirms linagliptin’s renal, CV safety, but it’s still third-line for type 2 diabetes
- Author:
- M. Alexander Otto
SAN FRANCISCO – The study was unusual among other DPP-4 trials in that almost 60% of the patients were older than 65, and 62.3% had impaired renal...
News
BMI screening trigger for type 2 diabetes is unreliable for at-risk black, Hispanic adults
- Author:
- M. Alexander Otto
SAN FRANCISCO – One risk factor should trigger screening in normal weight.
News
Low-fat dairy associated with decreased risk of type 2 diabetes
- Author:
- M. Alexander Otto
SAN FRANCISCO – An indicator of healthy living, or a true effect?
News
Type 2 diabetes is particularly devastating in adolescents
- Author:
- M. Alexander Otto
SAN FRANCISCO – “These kids have problems you’d expect in their grandparents.” – Dr....
News
Misguided fear is keeping benzodiazepines from elderly
- Author:
- M. Alexander Otto
SAN FRANCISCO – Benzos are “wonderful” for geriatric anxiety and anxiety-related insomnia, said Dr. Carl Salzman of Harvard Medical School.
News
VOC-sniffing necklace may support early detection of hypoglycemia
- Author:
- M. Alexander Otto
SAN FRANCISCO – Same trick as diabetes alert dogs – minus the pup.
News
CAROLINA findings reaffirm linagliptin’s safety, free glimepiride of CV-risk stigma
- Author:
- M. Alexander Otto
SAN FRANCISCO – Concerns remain around glimepiride-related weight gain and hypoglycemia.
News
Ketamine edges out ECT for refractory depression in small study
- Author:
- M. Alexander Otto
ECT maybe more durable than ketamine as a treatment.
News
Daratumumab wins new indication for newly diagnosed myeloma patients
- Author:
- M. Alexander Otto
Daratumumab plus lenalidomide and dexamethasone (DRd) is now approved for newly diagnosed myeloma patients who are ineligible for autologous stem...
News
Medical cannabis legalization outpacing evidence
- Author:
- M. Alexander Otto
SAN FRANCISCO – Sparse evidence on cannabis is based on observational studies – not RCTs, said Dr. Kevin P. Hill.